vs
Side-by-side financial comparison of ESCO TECHNOLOGIES INC (ESE) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $289.7M, roughly 1.4× ESCO TECHNOLOGIES INC). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs 5.3%, a 4.6% gap on every dollar of revenue.
Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
ESE vs GRDN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $289.7M | $397.6M |
| Net Profit | $28.7M | $20.9M |
| Gross Margin | 41.4% | 21.5% |
| Operating Margin | 13.2% | 7.7% |
| Net Margin | 9.9% | 5.3% |
| Revenue YoY | 17.3% | — |
| Net Profit YoY | 22.2% | — |
| EPS (diluted) | $1.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $289.7M | $397.6M | ||
| Q3 25 | $286.5M | $377.4M | ||
| Q2 25 | $296.3M | $344.3M | ||
| Q1 25 | $265.5M | $329.3M | ||
| Q4 24 | $247.0M | — | ||
| Q3 24 | $298.5M | $314.4M | ||
| Q2 24 | $260.8M | — | ||
| Q1 24 | $249.1M | — |
| Q4 25 | $28.7M | $20.9M | ||
| Q3 25 | $218.7M | $9.8M | ||
| Q2 25 | $26.1M | $9.0M | ||
| Q1 25 | $31.0M | $9.4M | ||
| Q4 24 | $23.5M | — | ||
| Q3 24 | $34.3M | $-122.0M | ||
| Q2 24 | $29.2M | — | ||
| Q1 24 | $23.2M | — |
| Q4 25 | 41.4% | 21.5% | ||
| Q3 25 | 45.9% | 19.8% | ||
| Q2 25 | 41.2% | 19.8% | ||
| Q1 25 | 41.1% | 19.5% | ||
| Q4 24 | 39.8% | — | ||
| Q3 24 | 40.1% | 19.4% | ||
| Q2 24 | 39.6% | — | ||
| Q1 24 | 38.8% | — |
| Q4 25 | 13.2% | 7.7% | ||
| Q3 25 | 17.2% | 4.3% | ||
| Q2 25 | 11.2% | 3.7% | ||
| Q1 25 | 15.3% | 3.9% | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | 14.8% | -33.3% | ||
| Q2 24 | 14.3% | — | ||
| Q1 24 | 11.7% | — |
| Q4 25 | 9.9% | 5.3% | ||
| Q3 25 | 76.3% | 2.6% | ||
| Q2 25 | 8.8% | 2.6% | ||
| Q1 25 | 11.7% | 2.9% | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 11.5% | -38.8% | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | 9.3% | — |
| Q4 25 | $1.11 | — | ||
| Q3 25 | $8.43 | — | ||
| Q2 25 | $1.01 | — | ||
| Q1 25 | $1.20 | — | ||
| Q4 24 | $0.91 | — | ||
| Q3 24 | $1.32 | — | ||
| Q2 24 | $1.13 | — | ||
| Q1 24 | $0.90 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.8M | $65.6M |
| Total DebtLower is stronger | $145.5M | $0 |
| Stockholders' EquityBook value | $1.6B | $217.9M |
| Total Assets | $2.4B | $412.7M |
| Debt / EquityLower = less leverage | 0.09× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.8M | $65.6M | ||
| Q3 25 | $101.3M | $36.5M | ||
| Q2 25 | $78.7M | $18.8M | ||
| Q1 25 | $57.4M | $14.0M | ||
| Q4 24 | $71.3M | — | ||
| Q3 24 | $66.0M | $37.2M | ||
| Q2 24 | $63.0M | — | ||
| Q1 24 | $59.4M | — |
| Q4 25 | $145.5M | $0 | ||
| Q3 25 | $186.0M | — | ||
| Q2 25 | $525.0M | — | ||
| Q1 25 | $88.0M | — | ||
| Q4 24 | $112.0M | — | ||
| Q3 24 | $122.0M | $34.3M | ||
| Q2 24 | $173.0M | — | ||
| Q1 24 | $191.0M | — |
| Q4 25 | $1.6B | $217.9M | ||
| Q3 25 | $1.5B | $195.5M | ||
| Q2 25 | $1.3B | $179.7M | ||
| Q1 25 | $1.3B | $163.2M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | $133.9M | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $2.4B | $412.7M | ||
| Q3 25 | $2.4B | $390.0M | ||
| Q2 25 | $2.5B | $356.3M | ||
| Q1 25 | $1.8B | $334.0M | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.8B | $348.0M | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.8B | — |
| Q4 25 | 0.09× | 0.00× | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.09× | — | ||
| Q3 24 | 0.10× | 0.26× | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.9M | $34.6M |
| Free Cash FlowOCF − Capex | $63.0M | — |
| FCF MarginFCF / Revenue | 21.7% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 2.40× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $239.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.9M | $34.6M | ||
| Q3 25 | $109.9M | $28.2M | ||
| Q2 25 | $73.7M | $19.9M | ||
| Q1 25 | $24.1M | $17.6M | ||
| Q4 24 | $34.2M | — | ||
| Q3 24 | $72.1M | — | ||
| Q2 24 | $36.2M | — | ||
| Q1 24 | $10.5M | — |
| Q4 25 | $63.0M | — | ||
| Q3 25 | $97.8M | $24.2M | ||
| Q2 25 | $64.9M | — | ||
| Q1 25 | $14.0M | — | ||
| Q4 24 | $29.0M | — | ||
| Q3 24 | $60.9M | — | ||
| Q2 24 | $27.6M | — | ||
| Q1 24 | $2.0M | — |
| Q4 25 | 21.7% | — | ||
| Q3 25 | 34.1% | 6.4% | ||
| Q2 25 | 21.9% | — | ||
| Q1 25 | 5.3% | — | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 10.6% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 4.2% | 1.1% | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 2.40× | 1.65× | ||
| Q3 25 | 0.50× | 2.87× | ||
| Q2 25 | 2.83× | 2.21× | ||
| Q1 25 | 0.78× | 1.86× | ||
| Q4 24 | 1.46× | — | ||
| Q3 24 | 2.10× | — | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 0.45× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESE
| US Government | $98.0M | 34% |
| Utility Solutions Group | $87.5M | 30% |
| RF Shielding And Test | $58.3M | 20% |
| Commercial | $45.8M | 16% |
| Related Party | $1.3M | 0% |
GRDN
Segment breakdown not available.
